GSK pharma head flags need for speed in high-pressure drug market
Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain's largest drugmaker told Reuters.
from Reuters: Health News https://reut.rs/2WJAyjP
http://bit.ly/2zwRqiM
June 17, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on June 17, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.